Dassault to acquire ArisGlobal for compliance AI

Key Takeaways

• Dassault Systèmes to acquire ArisGlobal for approximately $1.8 billion
• ArisGlobal's AI-native compliance platform serves over 200 customers in the Life Sciences industry
• The acquisition is expected to deliver revenue synergies and be accretive to revenue growth and EPS in Year 1
• ArisGlobal's revenue is expected to reach $175 million in 2026
• The compliance market is projected to grow to $7.5 billion by 2030

Introduction to the Acquisition

Dassault Systèmes has announced the signing of a definitive agreement to acquire ArisGlobal, a leading provider of AI-native enterprise compliance platforms for the Life Sciences industry. The acquisition is valued at approximately $1.8 billion in cash at closing, with an additional $200 million in consideration linked to AI-related revenue milestones.

About ArisGlobal

ArisGlobal's platform serves over 200 customers, including half of the top 50 global biopharma companies, as well as biotech, medtech, and global health authorities. The company's regulated core platform processes over 12 million patient safety reports annually and has over 1,300 employees globally. ArisGlobal's NavaX AI platform delivers more than 30% productivity gains, helping customers automate complex processes and improve data quality.

Market Outlook

The compliance market is projected to grow to $7.5 billion by 2030, with software and AI expected to capture an increasing share of total spend. ArisGlobal operates in a highly resilient market, with its innovative technology solutions deployed horizontally to track and manage global patient safety events, medical affairs, and quality processes.

Comparison of Dassault Systèmes and ArisGlobal

Benefits of the Acquisition

The acquisition of ArisGlobal advances Dassault Systèmes' ambition to transform the Life Sciences industry by combining its domain expertise with ArisGlobal's leadership in regulated operations and real-world evidence management. The acquisition is expected to deliver revenue synergies and be accretive to revenue growth and EPS in Year 1.

Bottom Line

The acquisition of ArisGlobal by Dassault Systèmes is a strategic move to strengthen its position in the Life Sciences industry. With ArisGlobal's AI-native compliance platform and Dassault Systèmes' domain expertise, the combined entity is expected to deliver innovative solutions to the industry, driving growth and improving patient outcomes. The acquisition is expected to close in the second half of 2026, subject to regulatory approvals and customary conditions.